Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1150 of 1467 entries
View as:

A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

Phase: N/A Priority: Normal
NCT ID: NCT05819112 Org: User:
Start: 04/25/23 End: 12/15/23 Due: 12/15/24

A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)

Phase: N/A Priority: Normal
NCT ID: NCT04848779 Org: User:
Start: 06/10/21 End: 10/28/26 Due: 10/28/27

Safety and Tolerability of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease

Phase: N/A Priority: Normal
NCT ID: NCT01157156 Org: User:
Start: 06/30/99 End: 09/30/01 Due: 09/30/02

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00356122 Org: User:
Start: 07/31/06 End: 08/31/10 Due: 08/31/11

Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00772525 Org: User:
Start: 09/30/08 End: 06/30/09 Due: 06/30/10

A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00545246 Org: User:
Start: 10/31/07 End: 07/31/12 Due: 07/31/13

Japanese Dose-Response Study of Rimonabant in Obese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00459004 Org: User:
Start: 10/31/04 End: 04/30/06 Due: 04/30/07

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

Phase: N/A Priority: Normal
NCT ID: NCT05104567 Org: User:
Start: 12/09/21 End: 09/09/24 Due: 09/09/25

Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01670734 Org: User:
Start: 09/30/12 End: 05/31/13 Due: 05/31/14

SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.

Phase: N/A Priority: Normal
NCT ID: NCT00460733 Org: User:
Start: 03/31/07 End: 09/30/11 Due: 09/30/12

Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT02343926 Org: User:
Start: 12/31/14 End: 04/30/16 Due: 04/30/17

Tax First-line Chemotherapy With Different Doses and Then Maintenance Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01038661 Org: User:
Start: 11/30/09 End: 08/31/12 Due: 08/31/13

Comparison of the Pharmacokinetics and Safety of Two SAR231893 (REGN668) Drug Products in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01537640 Org: User:
Start: 02/29/12 End: 07/31/12 Due: 07/31/13

An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT02890992 Org: User:
Start: 09/15/16 End: 02/22/19 Due: 02/22/20

A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI

Phase: N/A Priority: Normal
NCT ID: NCT03236311 Org: User:
Start: 10/12/17 End: 07/23/18 Due: 07/23/19

Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00494338 Org: User:
Start: 11/30/04 End: 04/30/05 Due: 04/30/06

Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease

Phase: N/A Priority: Normal
NCT ID: NCT00862420 Org: User:
Start: 02/28/09 End: 05/31/11 Due: 05/31/12

Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT03889639 Org: User:
Start: 03/29/19 End: 01/02/20 Due: 01/02/21

A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine

Phase: N/A Priority: Normal
NCT ID: NCT06087627 Org: User:
Start: 12/27/23 End: 12/28/26 Due: 12/28/27

Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)

Phase: N/A Priority: Normal
NCT ID: NCT02107898 Org: User:
Start: 03/31/14 End: 09/30/15 Due: 09/30/16

Insulin Glulisine in Diabetes Mellitus, Type 2

Phase: N/A Priority: Normal
NCT ID: NCT00174668 Org: User:
Start: 11/30/04 End: - Due: -

Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.

Phase: N/A Priority: Normal
NCT ID: NCT03703869 Org: User:
Start: 03/06/18 End: 02/24/20 Due: 02/24/21

Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro

Phase: N/A Priority: Normal
NCT ID: NCT00296179 Org: User:
Start: 02/28/06 End: - Due: -

HENOX: Enoxaparine in Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00347490 Org: User:
Start: 05/31/06 End: 06/30/07 Due: 06/30/08

Insulin Glargine in Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00272090 Org: User:
Start: 11/30/02 End: 12/31/05 Due: 12/31/06